Table 2 Association between neutrophil/lymphocyte ratio, National Institute of Health Stroke Scale (NIHSS), and Modified Rankin Scale (mRS) among the studied patients
From: Role of some inflammatory biomarkers in prediction of short-term outcome in acute ischemic stroke
| Â | Neutrophil/lymphocyte ratio | Test of sig. | P value | |||
|---|---|---|---|---|---|---|
<2 (n = 13) | 2-3 (n = 8) | >3 (n = 39) | ||||
NIHSS, median (range) | At admission | 10 (6–17) | 14.5 (7–19) | 13 (5–21) | KW 4.3 | 0.1 |
1 week post-stroke | 9 (4–16) | 11.5 (5–19) | 11 (3–22) | KW 4.2 | 0.1 | |
2 weeks post-stroke | 6 (4–13) | 10 (5–22) | 9 (3–22) | KW 4.9 | 0.08 | |
mRS, N (%) | Favorable (0–2) | 10 (76.9) | 4 (50.0) | 10 (25.6) | χ2 10.9 | <0.001** |
Unfavorable (>2) | 10 (23.1) | 4 (50.0) | 10 (74.4) | |||